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of this fraction in β 2 -AR-KO mice. The relaxation response 
with low sensitivity to (-)-isoprenaline was not affected by 
any of the β-AR subtype-selective blockers and was the only 
response detected in detrusor strips from β 2 -AR-KO mice. 
 Conclusions:  In CCh-pre-contracted mouse detrusor, β 2 -
ARs are responsible for the relaxation component with high 
sensitivity to (-)-isoprenaline as indicated by the conversion 
of a biphasic into a monophasic CRC with ICI 118,551 or by 
its absence in β 2 -AR KO mice. The mucosa does not impair 
relaxation under these conditions.   © 2015 S. Karger AG, Basel 
 Introduction 
 The urothelium is part of the mucosa of the lower uri-
nary tract and lines the inner surface of the urinary blad-
der. Besides protecting the bladder wall against aggressive 
constituents of the urine, the urothelium is also involved 
in sensing mechanical stress and regulating contractile 
function of the detrusor  [1, 2] . 
 The precise mechanisms by which the urothelium 
modulates contraction are not fully understood. In-vitro 
experiments with intact and mucosa-denuded detrusor 
strips provided conflicting results in various species. 
Maximum KCl-stimulated contractions of human and 
murine muscle strips are lower in intact strips than when 
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 Abstract 
 Aims: To study the β-adrenoceptor subtypes involved in the 
relaxation responses to (-)-isoprenaline in carbachol-pre-
contracted (CCh) mouse detrusor muscle with intact and de-
nuded mucosa.  Methods: Isolated muscle strips from the uri-
nary bladder of male C57BL6 mice or β 2 -adrenoceptor 
knockout mice were pre-contracted with CCh, 1 μ M and re-
laxed with increasing concentrations of the β-adrenoceptor 
(β-AR) agonist (-)-isoprenaline and forskolin. For estimating 
the β-AR subtypes involved, subtype-selective receptor 
blockers were used, that is, CGP 20712A (β 1 -ARs), ICI 118,551 
(β 2 -ARs), and L748,337 (β 3 -ARs).  Results: Unlike in KCl-pre-
contracted muscle, the mucosa did not affect the sensitivity 
of the relaxation response to (-)-isoprenaline in CCh-pre-
contracted murine detrusor strips. Increasing concentra-
tions of (-)-isoprenaline produced a biphasic concentration-
relaxation response without any difference both during the 
presence and absence of mucosa. The relaxation fraction 
produced by low (-)-isoprenaline concentrations was medi-
ated by β 2 -AR as evidenced by a shift of the concentration-
response curve to higher concentrations with ICI 118,551, 
but not with CGP 20712A and L748,337, and by the absence 
 Received: September 1, 2014 
 Accepted after revision: September 16, 2014 
 Published online:  January 30, 2015 
Internationalis
Urologia
 Dr. med. Stefan Propping 
 Institute and Outpatient Clinics of Urology, Medizinische Fakultät Carl Gustav Carus
Technische Universität Dresden ,  Fetscherstrasse 74 
 DE–01307 Dresden (Germany) 
 E-Mail stefan.propping   @   uniklinikum-dresden.de 
 © 2015 S. Karger AG, Basel
0042–1138/15/0951–0092$39.50/0 
 www.karger.com/uin 
D
ow
nl
oa
de
d 
by
: 
S
ta
at
s-
 u
nd
 L
an
de
sb
ib
lio
th
ek
 D
re
sd
en
   
   
   
   
   
   
 
21
2.
20
1.
53
.1
19
 -
 5
/2
4/
20
16
 2
:1
2:
54
 P
M
 β-AR-Mediated Relaxation of 
Pre-Contracted Mouse Detrusor 
 Urol Int 2015;95:92–98 
DOI: 10.1159/000369075
93
the urothelium has been removed  [3, 4] , although some 
groups did not find any difference  [5] . In several species, 
contractions elicited via muscarinic receptor stimulation 
are also smaller in intact than denuded detrusor strips 
 [4–11] , suggesting that the urothelium exerts a relaxing 
effect on bladder muscle, which is assumed to be medi-
ated by an unknown diffusible factor. The specific char-
acteristic of this ‘urothelium-derived relaxing factor’ has 
not been determined  [5, 7] . On the other hand, there is 
also evidence for indirect backup of contraction by the 
urothelium. For instance, higher concentrations of 
(-)-noradrenaline and (-)-isoprenaline are needed for 
the relaxation of carbachol (CCh)-pre-contracted intact 
than  mucosa-denuded detrusor from pig and human 
bladder  [4, 11, 12] . We reported similar findings in KCl-
pre-contracted murine muscle strips  [3], suggesting that 
the urothelium antagonizes relaxation mediated via 
β-adrenoceptors (β-AR). 
 Relaxation of CCh-stimulated detrusor strips with 
(-)-isoproterenol is mediated via different β-AR sub-
types in mouse (β 2 -AR) and man (β 3 -AR)  [13] . We also 
noted different sensitivities to β-AR stimulation be-
tween intact and denuded strips from human and 
mouse muscle. Interestingly, different β-AR subtypes 
are involved in the mucosa’s modulating properties. In 
man, relaxation of KCl-pre-contracted detrusor strips 
was mediated by β 3 -ARs but the effect of the mucosa on 
the relaxation response to (-)-isoprenaline mediated via 
mucosal β 2 -ARs, whereas in mouse, both responses are 
mediated by β 2 -ARs, suggesting that the activation of 
mucosal β 2 -ARs reduces β-AR-mediated detrusor re-
laxation irrespective of the β-AR sub-type involved  [3, 
4] .
 In the present study, we investigated whether the mu-
cosa can also modulate  (-)-isoprenaline-induced relax-
ation of CCh-pre-contracted mouse detrusor muscle and 
characterized the β-AR subtypes are involved. We found 
similar biphasic concentration-response curves for 
(-)-isoprenaline in intact and denuded strips and the high 
sensitivity fraction of the response was mediated via β 2 -
ARs.
 Materials and Methods  
 The study was conducted according to European Commission 
Directive 86/609/EEC regarding the protection and welfare of an-
imals used for experimental as well as scientific purposes. All ani-
mal experiments were performed in accordance with the regula-
tions of the local council committee (permission number 24D-
9168.24–1/2007–17 of the Regierungspräsidium, Dresden).
 Animals 
 Male C57BL6 [Charles River, Margate, Kent, UK] wild type and 
homozygote β 2- AR knockout mice in mixed C57BL/6J/FVB/N 
background, bred in the laboratory in Würzburg, were used  [14] . 
The age of the mice ranged from 9 to 15 months and their body 
weight ranged from 20–30 g. All mice were group-housed in cages 
with free access to food and water at least 4 days before the exper-
iments were conducted. 
 Preparation of Detrusor Muscle Strips 
 Mice were sacrificed by cervical dislocation. The whole urinary 
bladder was resected at the bladder neck. After removal of the 
dome and the neck of the bladder, the remaining muscle ring was 
opened longitudinally. The mucosa was removed from half of the 
preparations, but remained intact in the other half. Four strips of 
smooth muscle around 3–4 mm long and 1–2 mm wide were pre-
pared.
 Drugs and Solutions 
 The modified Tyrode’s solution contained (in m M /l): NaCl 
126.9, KCl 5.4, MgCl 2 1.05, CaCl 2 1.8, NaH 2 HPO 4 0.45, NaHCO 3 
22, EDTA 0.04, ascorbic acid 0.2, and glucose 5.6, pH 7.4, when 
equilibrated with 95% O 2 and 5% CO 2 . Drugs and chemicals were 
obtained from Sigma (St. Louis, Mo., USA) and Tocris Bioscience 
(Bristol, UK). All drugs were dissolved in Milli-Q water (Millipore, 
Billerica, Mass., USA), with the exception of (-)-isoprenaline, 
which was dissolved in water containing 200 m M ascorbic acid and 
40 m M EDTA. L748,337 and forskolin were dissolved in dimethyl 
sulfoxide and stock solutions were further diluted with Milli-Q 
water. The maximum concentration of dimethyl sulfoxide in the 
organ bath did not exceed 0.1%. 
 Pre-Contraction and Relaxation of Urinary Smooth Muscle 
 All preparations were mounted in 5-ml organ baths containing 
carbogen-gassed, modified Tyrode’s solution at 37   °   C. Tension 
was measured with an isometric force transducer (GM 2, Föhr 
Medical Instruments, Seeheim/Ober-Beerbach, Germany), am-
plified and recorded with Chart 4.0 TM (ADInstruments, Sydney, 
Australia). Resting load was 5 mN. The force of detrusor contrac-
tion was expressed as mN/mg wet weight (w.w.) of each muscle 
strip.
 During a 60-min episode of equilibration the Tyrode’s solution 
was replaced every 20 min conditioning muscle contractions were 
elicited to times by increasing the KCl concentration in the bath 
solution to 40 m M for 5 min followed by washout without compen-
sation for increase in osmolality. To exclude any T-AR-mediated 
process, phentolamine (3 μ M ) and prazosin (1 μ M ) were added. 
After a resting time of 45 min, muscle strips were pre-contracted 
with 1 μ M CCh and responses became stable within 45 min. Relax-
ation was then induced by cumulatively increasing concentrations 
of (-)-isoprenaline (10 p M –300 μ M ) and maximum relaxation was 
tested with 10 μ M forskolin. Involvement of β-AR subtypes in the 
responses was tested by incubating the strips 30 min prior to CCh 
stimulation with a single or a combination of β-AR subtype-selec-
tive antagonists, that is, CGP 20712A (300 n M ) for β 1 -ARs, ICI 
118,551 (50 n M ) for β 2 -ARs, and L748,337 (100 n M , 300 n M or 
1 μ M ) for β 3 -ARs. Time-matched control experiments of CCh-in-
duced detrusor contractions in the presence of phentolamine 
(3 μ M ) and prazosin (1 μ M ) were run in the absence of a β -AR 
agonist or antagonist.
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 Data Analysis and Statistics 
 Concentration-response curves (CRCs) for (-)-isoprenaline 
were analyzed by nonlinear regression of each individual experi-
ment using GraphPad 4.0 (GaphPad Prism Software Inc., San Di-
ego, Calif., USA). The negative common logarithm of the molar 
concentration producing 50% of the maximum relaxing effect 
(– logEC 50 [M]) was calculated. The values of  table 1 are mean val-
ues ± SEM from n muscle strips. Strips from the same mouse were 
used in different experimental groups, so that the number of strips 
in each group is equal to the number of mice. 
 The figures of nonlinear regression curves were obtained by 
fitting sigmoidal functions to the mean data points, whereas the 
–logEC 50 values of  table 1 are the mean values obtained from curve 
fitting to data of individual experiments. Statistical differences 
were evaluated by using paired or unpaired Student’s  t -test and 
 ANOVA with an additional  Bonferroni comparison test. A value 
of p < 0.05 was considered statistically significant.
 Results 
 The force of contraction rapidly increased after the ad-
dition of CCh (1 μ M ) to a peak value (F max ) and then de-
clined to a steady state value within 30 min (F ss ;  fig. 1 a, b). 
Since the preparations developed strong spontaneous ac-
tivity, tension was measured as the difference between 
baseline and the lowest force development during a spon-
taneous contraction cycle. The addition of cumulatively 
increasing concentrations of (-)-isoprenaline relaxed the 
muscle strips and maximum relaxation (R max ) was 
achieved with forskolin (10 μ M ). F max and F ss with CCh, 
but also force at R max in the presence of forskolin were 
significantly larger in urothelium-denuded than intact 
detrusor strips ( fig. 1 c). These results are in line with the 
existence of an ‘urothelium-derived relaxing factor  [3–5, 
7] . Tension decline of CCh-induced contraction in a sim-
ilar time window as required for the (-)-isoprenaline ap-
plication (time-matched controls, TMC) was 13 ± 2% in 
intact and 14 ± 4% in denuded strips.
 Figure 2 depicts CRC for (-)-isoprenaline in intact and 
denuded strips under control conditions and in the pres-
ence of β-AR subtype selective blockers. The relaxation 
curves showed a highly significant better fit by a biphasic 
than a monophasic sigmoidal function ( table 1 ). Approx-
imately, half of the CCh-induced force relaxed with an 
EC 50 value in the nanomolar and the other half in the mi-
cromolar concentration range (–logEC 50 [M] of 9.21 and 
5.86, respectively). There were no significant differences 
Table 1.  Relaxing effects of cumulative added (-)-isoprenaline (10 pM–300 μM) in murine detrusor muscle strips with intact and de-
nuded mucosa pre-contracted with 1 μM carbachol (CCh) and the influence of selective β-AR antagonists
Subtype-selective antagonist Intact mucosa  Denuded mucosa
high sensitivity 
component 
low sensitivity 
component
n high sen sitivity 
component
low sensitivity 
component
n
–logEC50 
[M]
Emax 
[%]
–logEC50 
[M]
Emax 
[%]
–logEC50 
[M]
Emax 
[%]
–logEC50 
[M]
Emax 
[%]
none (= control) 9.21±0.38 33±3 5.86±0.41 36±3 13/13 9.21±0.46 41±4 5.86±0.45 32±2 11/11
+300 nM CGP 20712A 8.02±0.16 36±6 5.06±0.24 42±4 5/5 7.60±0.83 32±7 5.95±0.88 48±6## 5/5
+50 nM ICI 118,551 – – 5.93±0.11 72±4### 7/7 – – 5.93±0.16 73±7### 7/7
+100 nM L 748,337 7.99±0.01 49±5 4.89±0.16 33±1 4/4 8.50±0.46 46±9 5.52±0.65 36±9 4/4
+300 nM L748,337 9.02±0.76 32±6 4.97±1.01 36±2 4/4 8.29±0.12 67±3# 4.88±0.21 56±2 4/4
+1 μM L748,337 9.73±1.01 44±15 7.49±1.36 32±8 4/4 9.64±0.67 22±5# 6.06±1.20 44±2 4/4
+300 nM CGP 20712A, +100 nM L748,337 8.06±0.18# 30±5 4.87±0.16 48±7 8/6 7.93±0.19# 30±2 4.69±0.08 46±3## 7/6
+300 nM CGP 20712A, +50 nM ICI 118,551 – – 6.03±0.14 72±7### 5/5 – – 6.03±0.11 80±3### 4/4
+50 nM ICI 118,551, +100 nM L748,337 – – 5.90±0.06 65±4### 5/5 – – 5.93±0.07 72±4### 5/5
+300 nM CGP 20712A, +50 nM ICI 118,551 
+100 nM L748,337
– – 5.72±0.13 73±5### 8/8 – – 5.62±0.28 76±2### 7/7
β2-AR KO – – 5.77±0.17 50±3## 15/8 – – 5.57±0.17 52±4### 10/8
 –logEC50 = Negative logarithm of the concentration of (-)-isoprenaline required for half-maximum relaxation in the absence or presence of extra 
drug; Emax = maximum response in % of response to 10 μM forskolin (100%); values are mean values obtained from curve fitting to data of individual 
experiments; n = number of mice/number of detrusor strips.
Values compared with respective values in control strips. # p < 0.05; ## p < 0.01; ### p < 0.001.
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in sensitivity to (-)-isoprenaline between intact and de-
nuded muscles both with respect to potency and efficacy 
(see  table 1 ). 
 Pre-incubation with the subtype selective β-AR block-
ers had no effect on F max , F ss and R max (data not shown). 
None of the β-AR blockers affected the portion of relax-
ation with low sensitivity to (-)-isoprenaline, neither 
alone nor in any combination ( fig. 2 ). The β 1 -AR blocker 
CGP 20712A (300 n M ) had no effect on the (-)-isoprena-
line CRC in denuded detrusor, whereas the highly (-)-iso-
prenaline sensitive fraction of the response was shifted to 
higher concentrations and became slightly smaller, but 
this effect did not reach the level of significance ( fig. 2 a). 
The β 2 -AR blocker ICI 118,551 (50 n M ) strongly shifted 
the high sensitivity portion of the CRC by about 2 log 
units to the right ( fig. 2 b), so that the CRCs became mono-
phasic. They remained similar in intact and denuded 
strips. The β 3 -AR blocker L748,337 (100 n M ) was without 
any effect on the CRCs ( fig. 2 c). We then tested whether 
the combination of β-AR blockers could produce any ad-
ditional effects. The combination of CGP 20712A and 
L748,337 significantly shifted the CRC for the high sensi-
tivity response to the right by almost one log unit. The 
relative size of this portion tended to be smaller, that is, 
30 versus 36% of R max (see  table 1 ), but the difference did 
not reach the level of significance ( fig. 2 d). Any combina-
tion of the other 2 blockers with ICI 118,551 produced the 
same effect as the β 2 -AR blocker alone ( fig. 2 e, f; see on-
line suppl. fig. S1; for all online suppl. material, see www.
karger.com/doi/10.1159/000369075) for ICI 118,551 plus 
L748,337. All CRCs were similar in intact and denuded 
muscle strips.
 The above findings suggest the prominent role of β 2 -
ARs in mediating  (-)-Isoprenaline-induced relaxation in 
CCh-pre-contracted mouse detrusor. This was further 
confirmed in detrusor strips from β 2 -AR-KO mice ( fig. 3 ). 
In these preparations, the high sensitivity component of 
the CRC to (-)-isoprenaline was absent, and only a low 
Fss
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20 min
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CCh, 1 μM 
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N
c *
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 Fig. 1. Relaxation of CCh-induced contraction of mouse detrusor 
by (-)-isoprenaline.  a Original tracing of force contraction of intact 
or mucosa-denuded detrusor strips after addition of CCh, 1 μ M 
and cumulatively increasing concentrations of (-)-isoprenaline 
(increments in half log units). The force in the presence of 10 μ M 
forskolin defined the level of maximum relaxation (100%).  b Sche-
matic presentation of peak (F max ) and steady-state (F ss ) force of 
contraction induced by CCh and maximum relaxation (R max ). 
 c  Mean values for CCh-induced F max , F ss and R max in  intact and 
denuded detrusor strips. Means ± SEM, numbers indicate number 
of strips.   *   p < 0.05;  * *  p < 0.01;  * * *  p < 0.001. 
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 Fig. 2. Concentration-response curves for (-)-isoprenaline-in-
duced relaxation of intact and denuded, CCh-pre-contracted de-
trusor strips with and without β-AR subtype selective blockers. 
Monophasic or biphasic sigmoidal functions were fitted to the 
mean data points.  a CGP 20712A, 300 n M (β 1 -AR).  b ICI 118,551, 
50 n M (β 2 -AR).  c L748,337, 100 n M (β 3 -AR).  d CGP 20712A plus 
L748,337. ( e ) CGP 20712A plus ICI 118,551.  f CGP 20712A plus 
ICI 118,551 plus L748,337. For comparative purposes, all graphs 
contain the same control data set. Data are expressed in % of 
 maximum relaxation induced by 10 μ M forskolin (100%). Mean ± 
SEM, number of mice/number of detrusor strips.  
D
ow
nl
oa
de
d 
by
: 
S
ta
at
s-
 u
nd
 L
an
de
sb
ib
lio
th
ek
 D
re
sd
en
   
   
   
   
   
   
 
21
2.
20
1.
53
.1
19
 -
 5
/2
4/
20
16
 2
:1
2:
54
 P
M
 β-AR-Mediated Relaxation of 
Pre-Contracted Mouse Detrusor 
 Urol Int 2015;95:92–98 
DOI: 10.1159/000369075
97
sensitivity response of about 50% of the maximum for-
skolin relaxation was observed. Both denuded and intact 
CCh-stimulated muscles without β 2 -AR relaxed with 
similar sensitivity to (-)-isoprenaline.
 Discussion 
 The objective of the present study was to characterize 
β-AR-mediated relaxation in the CCh-pre-contracted de-
trusor muscle strips of mice. Our major findings were 
that (i) the mucosa does not have any influence on the 
relaxation response under these conditions and (ii) 
(-)-isoprenaline-induced relaxation occurs in two con-
centration ranges with the response at low concentrations 
being mediated via β 2 -ARs.
 We have shown previously, that the presence of the 
mucosa attenuates the contractile response to KCl sup-
porting the existence of an urothelium-derived relaxing 
factor  [3, 4] ; however, others could not demonstrate this 
effect  [5] . Our study also provided evidence that the mu-
cosa may impair relaxation in response to (-)-isoprena-
line. Here we confirm that the inhibitory role of murine 
urothelium is also observed in CCh-stimulated muscles, 
but impairment of (-)-isoprenaline-induced relaxation 
could not be detected. It is not clear, why β-AR-stimulated 
relaxation is not blunted by the mucosa in CCh-pre-con-
tracted muscles (present study), although there is a clear 
effect in KCl-depolarized detrusor [Propping et al., 2014]. 
One reason could be that the small difference in sensitiv-
ity to β-AR agonists is difficult to detect, because both 
intact and denuded detrusor strips develop strong spon-
taneous contractile activity after stimulation with CCh 
(see  fig. 1 ). These spontaneous phasic contractions of de-
trusor muscle of many species seem to be mainly medi-
ated via M-receptors  [15, 16] . Another explanation may 
be sought in the well-accepted antagonism between M-
receptor and β-AR stimulation on cAMP production, in 
which M 2 receptors and β-ARs mediate reduction of ad-
enylyl cyclase activity via inhibitory G i -proteins and en-
hancement of enzyme activity via stimulating G s -pro-
teins, respectively  [17] . Such antagonism could also occur 
in the murine mucosa: the difference in the relaxation 
response to (-)-isoprenaline between intact and denuded 
murine muscles may be absent when mucosal cAMP lev-
els are kept low by block of β 2 -ARs  [3] or by the activation 
of M receptors in the CCh-pre-contracted muscles (pres-
ent study). 
 We and others reported previously that CCh-pre-con-
tracted detrusor from many species relaxed less complete-
ly with (-)-isoprenaline than KCl-pre-contracted strips 
 [18, 19] . In the present study, the relaxation response to 
(-)-isoprenaline after CCh stimulation was distinctly bi-
phasic, with about equal portions of high and low sensitiv-
ity to (-)-isoprenaline (compare  table  1 ). Others have 
found that (-)-isoprenaline is a weaker  relaxant against 
CCh- than KCl-stimulated detrusor  (– logEC 50 [M] 7.24 
vs. 5.32, respectively for rat detrusor)  [18] ; however, a bi-
phasic response may have escaped detection because 
CRCs were stopped at 10 μ M (-)-isoprenaline. 
 In any case, less complete relaxation responses for 
CCh- than for KCl-pre-contracted muscles in the low 
(-)-isoprenaline concentration range may be explained 
by stimulatory effects of M receptor activation on detru-
sor contractions. While activation of M 3 receptors may 
counteract β 2 -AR-mediated relaxation by directly stimu-
lating detrusor contractions via enhanced intracellular 
Ca 2+ release  [17] , activation of M 2 receptors may oppose 
relaxation by impairment of cAMP production  [20, 21] . 
However, some authors question a dominant contribu-
tion of cAMP increase to (-)-isoprenaline-induced relax-
ation, at least in rat urinary bladder  [19] . The nature of 
the relaxation response with low sensitivity to (-)-iso-
prenaline is not clear, but non-cAMP-mediated signals 
could be involved, including the activation of Ca 2+ -de-
pendent BK channels (Ca 2+ -activated K channels of big 
conduction)  [22] . Because of the very high (-)-isoprena-
line concentrations required, the low sensitivity response 
may not be of primary physiological importance. 
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 Fig. 3. Concentration-response curves for (-)-isoprenaline-in-
duced relaxation of intact and denuded, CCh-pre-contracted de-
trusor strips from WT and β 2 -AR KO mice. Same layout as in fig-
ure 2. 
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 The receptors mediating (-)-isoprenaline-induced re-
laxation of CCh-pre-contracted mouse detrusor are of 
the β 2 -AR subtype and thus the same as for KCl-stimu-
lated muscles  [3, 13] . This interpretation is supported by 
the shift in CRC with the β 2 -AR subtype-selective an-
tagonist ICI 118,551. The CRCs were not affected by tis-
sue exposure to either β1-AR- or β3-AR subtype selective 
antagonists, suggesting lack of involvement of β 1 -ARs or 
β 3 -ARs in relaxation of mouse detrusor. Nevertheless, 
β 3 -AR mediation was claimed using the β 3 -AR-selective 
agonist CL 316,243, but the relaxant potency of the selec-
tive β 3 -AR-agonist is low in mouse  [23] . We found a sta-
tistically significant shift in the CRCs with the combina-
tion of β 1 -AR and β 3 -AR antagonists (see  fig. 2 d), also 
suggesting minor involvement of other β-AR subtype. 
Since pharmacological identification of β-AR subtypes 
heavily depends on the properties of putatively selective 
antagonists, which is not necessarily always the case  [24] . 
We have also used β 2 -AR-KO mice to confirm the dom-
inant role of this β 2 -AR subtype in CCh-precontracted 
muscles. 
 Conclusions 
 In murine CCh-pre-contracted detrusor muscles, 
(-)-isoprenaline-induced relaxation in the low concentra-
tion range is mediated via β 2 -ARs. The presence of mu-
cosa in murine detrusor did not impair relaxation in re-
sponse to (-)-isoprenaline. 
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